Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
107117452 | 10711745 | 2 | F | 20160714 | 20150114 | 20160714 | EXP | TR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-006663 | BRISTOL MYERS SQUIBB | 35.00 | YR | F | Y | 0.00000 | 20160714 | OT | TR | TR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
107117452 | 10711745 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | 10 MG, QD | 21436 | 10 | MG | QD | |||||||
107117452 | 10711745 | 2 | I | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 200 UNK, UNK | 0 | 200 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
107117452 | 10711745 | 1 | Obsessive-compulsive disorder |
107117452 | 10711745 | 2 | Obsessive-compulsive disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
107117452 | 10711745 | HO |
107117452 | 10711745 | OT |
107117452 | 10711745 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
107117452 | 10711745 | Drug interaction | |
107117452 | 10711745 | Off label use | |
107117452 | 10711745 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |